Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis

<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.<br /><strong>Objective:</strong> to de...

Full description

Saved in:
Bibliographic Details
Main Authors: Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2022-10-01
Series:Medisur
Subjects:
esclerosis múltiple
esclerosis múltiple remitente-recurrente
interferón beta-1a
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/5396
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items